July/August 2022
This issue of Blood Cancers Today includes a feature on how chemotherapy-free regimens are more commonly being used for treatment, an interview with Guillermo Garcia-Manero, MD, President-Elect 2023 of SOHO, on what’s in store for the Society in the upcoming year, and more.
Viewpoints
Features
News
In the Literature
Frontline Ibrutinib Plus Standard Chemoimmunotherapy Shows Benefit in Untreated Mantle Cell Lymphoma
Meeting News
Regulatory Actions
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.